Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 29, 2021 - Issue 6
Submit an article Journal homepage
325
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Visual Acuity Outcome over Time in Non-Infectious Uveitis

Maxwell Pistillia The Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA;b The Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, The University of Pennsylvania School of Medicine, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0002-4266-4150View further author information
, MEd, MSORCID Icon,
Marshall M. Joffec The Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, The University of Pennsylvania School of Medicine, Philadelphia, PA, USAView further author information
, MD, MPH, PhD,
Sapna S. Gangaputrad Department of Ophthalmology and Vision Sciences, Vanderbilt Eye Institute, Nashville, TN, USAView further author information
, MD, MPH,
Siddharth S. Pujarie Om Eye Care Hospital, Belgaum, IndiaView further author information
, MBBS, MPH,
Douglas A. Jabsf Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA;g Departments of Ophthalmology and Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA;h Laboratory of Immunology, National Eye Institute, Bethesda, MD, USAView further author information
, MD, MBA,
Grace A. Levy-Clarkei Tampa Bay Uveitis Center, Tampa, FL, USA;j Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USAView further author information
, MD,
Robert B. Nussenblatth Laboratory of Immunology, National Eye Institute, Bethesda, MD, USAView further author information
, MD, MPH,
James T. Rosenbaumj Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA;k Department of Medicine, Oregon Health and Science University, Portland, OR, USAView further author information
, MD, FACR,
H. Nida Senh Laboratory of Immunology, National Eye Institute, Bethesda, MD, USAView further author information
, MD, MS,
Eric B. Suhlerj Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA;k Department of Medicine, Oregon Health and Science University, Portland, OR, USA;l Ophthalmology Service, Portland Veteran’s Affairs Medical Center, Portland, OR, USAView further author information
, MD, MPH,
Jennifer E. Thornef Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA;m Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information
, MD, PhD,
Nirali P. Bhatta The Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia, PA, USAView further author information
, MD,
C. Stephen Fostern Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA;o Department of Ophthalmology, Harvard Medical School, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-6612-5653View further author information
, MDORCID Icon,
Hosne Begumm Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information
, MBBS, MPH,
Tonetta D. Fitzgeralda The Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia, PA, USAView further author information
, BA,
Kurt A. Dregera The Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA;m Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information
, BS,
Michael M. Altaweelp The Fundus Photograph Reading Center, University of Wisconsin School of Medicine, Madison, WI, USA;q Department of Ophthalmology and Vision Sciences, University of Wisconsin School of Medicine, Madison, WI, USAView further author information
, MD,
Janet T. Holbrookf Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA;r Center for Clinical Trials and Synthesis, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USAView further author information
, PhD,
John H. Kempeno Department of Ophthalmology, Harvard Medical School, Boston, MA, USA;s Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA;t MCM Eye Unit, MCM General Hospital and MyungSung Medical School, Addis Ababa, EthiopiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2967-4792View further author information
, MD, PhDORCID Icon & Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group show all
Pages 1064-1071 | Received 13 Sep 2019, Accepted 29 Oct 2019, Published online: 10 Dec 2019

References

  • Ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol. Jan 29 1982;52(3–4):279–285.
  • National Advisory Eye Council (U.S.). Vision Research : A National Plan: 1983–1987. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health; 1983.
  • Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. Jul-Aug 2004;218(4):223–236.
  • Watson SL, Edelsten C, Kanski JJ The incidence of visual loss from uveitis. Poster presentation presented at Joint European Research Meetings in Ophthalmology and Vision; 1994; Montpellier, France.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. Sep 2005;140(3):509–516.
  • Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. Bmj. 2009;339:b2480.
  • Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) cohort study. Ophthalmic Epidemiol. Jan-Feb 2008;15(1):47–55.
  • Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. Jul 1982;94(1):91–96.
  • Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. Apr 2003;121(4):466–476.
  • Multicenter Uveitis Steroid Treatment Trial Research Group Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. Oct 2011;118(10):1916–1926.
  • Multicenter Uveitis Steroid Treatment Trial Research Group. Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four-month results of the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study. Ophthalmology. Oct 2015;122(10):1967–1975.
  • Kempen JH, Van Natta ML, Altaweel MM, et al. Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial. Am J Ophthalmol. Dec 2015;160(6):1133–1141 e1139.
  • Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. JAMA. May 16 2017;317(19):1993–2005.
  • Joffe MM, Pistilli M, Kempen JH. Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiol. 2013 Jul 2;20(4):197–200.
  • Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. Sep 2000;11(5):561–570.
  • Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. Dec 2014;121(12):2387–2392.
  • Kempen JH, Van Natta ML, Altaweel MM, et al. Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial. Am J Ophthalmol. Dec 2015;160(6):1133–1141 e1139.
  • Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014 Jun 28;158(4):676–692.
  • Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. Nov 1996;103(11):1846–1853.
  • DiLoreto DA Jr., Bressler NM, Bressler SB, Schachat AP. Use of best and final visual acuity outcomes in ophthalmological research. Arch Ophthalmol. Nov 2003;121(11):1586–1590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.